Sonnet BioTherapeutics Holdings, Inc.
SONN · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | – | $4,384 | $2,974 | $6,385 |
| - Cash | $5,120 | $149 | $2,274 | $3,053 |
| + Debt | $0 | $131 | $204 | $256 |
| Enterprise Value | – | $4,365 | $904 | $3,588 |
| Revenue | $1,000 | $19 | $148 | $350 |
| % Growth | 5,268.8% | -87.4% | -57.8% | – |
| Gross Profit | $0 | $19 | $148 | -$21,094 |
| % Margin | 0% | 100% | 100% | -6,027.9% |
| EBITDA | -$15,844 | -$11,766 | -$18,717 | -$29,576 |
| % Margin | -1,584.4% | -63,171.7% | -12,663.2% | -8,451.7% |
| Net Income | -$16,113 | -$7,437 | -$18,833 | -$29,774 |
| % Margin | -1,611.3% | -39,929.3% | -12,741.6% | -8,508.3% |
| EPS Diluted | -3.95 | -11.35 | -145.12 | -1,203.05 |
| % Growth | 65.2% | 92.2% | 87.9% | – |
| Operating Cash Flow | -$12,827 | -$8,608 | -$21,342 | -$27,687 |
| Capital Expenditures | $0 | $0 | -$443 | -$896 |
| Free Cash Flow | -$12,827 | -$8,608 | -$21,785 | -$28,584 |